Knockdown of MRPL21 attenuates the malignant phenotype of tumor cells, whereas its overexpression is closely linked to multiple tumor-related signaling pathways, regulating critical processes such as the G2M checkpoint and cell cycle progression, as well as being associated with key mutated genes in cancer. This evidence concerns the gene MRPL21 and cancer.